written by reader Covid 19 info

by colonel | September 8, 2020 8:54 pm

It may be of interest to you and other Gumshoe members regarding a new spray formulation for Covid 19 being developed by Starphama Holdings which has some unique and impressive results versus Remdesivir sensitivities and other antiviral[1] indications. They were just awarded a million dollars by the Australian Government to assist in the development of the drugs commercialization prospects.
I have owned this companies stock for a few years due to their dendrimer product used in other indications. Thanks for all the in depth info you provide on other promoted stocks. Keith Nelson

Endnotes:
  1. antiviral: https://www.stockgumshoe.com/tag/antiviral/

Source URL: https://www.stockgumshoe.com/2020/09/microblog-covid-19-info/


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.